Navigation Links
At 30, biotech is an industry at a crossroads

So just how old is the biotech industry? The July 2006 edition of MedAd News sustains that the industry has hit its 30th birthday this year. On Aug, 23, 2004, I wrote an article for this publication on "The Birth of Biotech: San Francisco, Boston, Geneva, or Chicago?"

In this ar......

Full article >>> llion, which grew 18 percent over the prior year (remember that the entire pharmaceutical industry grew 7 percent last year, and 5 percent in North America).
  • Losses of $4.3 billion, which decreased 30 percent from the prior year.
  • 32 new product approvals in the U.S., including 17 first-time approvals.
  • The second highest year for raising capital......

    Full article >>> companies.
  • Focus of cancer drugs on tumor types rather than tumor location: This dynamic is changing treatment modality in oncology. There are over 400 cancer drugs in development, and this development is changing how oncology clinical trials are being conducted. For example, it is not enough to say a patient has lung cancer today, as there are two broad types of lung can......

    Full article >>> nentech (U.S. - 1976)$6,633+44%$1,279+63%3. Genzyme (U.S. - 1981 )$2,735+24%$442+408%4. Serono (Switzerland - 1906 )**$2,586+5%<$105>N/A5. CSL (Australia - 1961)**$2,494+77%$419+149%6.......

    Full article >>> td>+49%22.Enzon Pharmaceuticals (U.S. - 1981)$166<2%><$90>N/A23.Vertex Pharmaceuticals (U.S. - 1989)$161+56%<$203><22%>24.Amylin Pharmaceuticals (U.S. - 1987)$141+315%<$207><32%>25.Berna Biotech (Switzerland - 1898)**
    Full article >>> 006

    Clearly, Amgen and Genentech are spending prodigious R&D sums, comparable to Big Pharma levels, but the next 3 yo 4 companies are not too far behind. This R&D is the life blood of a biotech company.

    All of the above trends noted by MedAd News really only focus on the drug part of biotech. As a result, I would add the following trends:



    Source:wistechnology.com By Michael Rosen 08/01/06


    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Olympics of biotechnology has international flavor
    3. Getting noticed in Genetown: Wisconsin biotech on display
    4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
    5. Wisconsin biotech firm receives $107K NIH grant
    6. Manufacturing partnership will move into biotech and biomedical spaces
    7. Wisconsin wont get Georgia biotech without a fight
    8. The 10 biggest events shaping biotech in 2006
    9. NimbleGen partners with UK biotech firm
    10. 2006: A great biotech financing year, unless you were going public!
    11. Big pharma seeks Wisconsin biotech partnerships
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/24/2017)... , Feb. 24, 2017  Driven by consumers, ... are now the fastest growing categories, finds the ... Actives in Personal Care: Multi-regional Market Analysis and ... management consulting firm Kline. "Biotechnology actives ... make them more effective for skin and hair ...
    (Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
    (Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
    (Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
    Breaking Biology Technology:
    (Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
    (Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
    (Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
    Breaking Biology News(10 mins):